Clinical Trial Update: The Norwegian Nucleoside Analogue Stop Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a nucleoside analogue in chronic hepatitis B; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Oslo University Hospital | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED